- New multidisciplinary clinic coordinates surgical, dental, hearing and speech services from infancy through adulthood
- Patients of all ages and nationalities can access personalized care, with insurance navigation and case-by-case support for eligible uninsured patients
Abu Dhabi, United Arab Emirates, 18 November 2026: Healthpoint, part of M42’s global network of healthcare providers, has inaugurated a dedicated Cleft Lip and Palate Clinic in Abu Dhabi, bringing specialist services together in one coordinated care pathway for newborns, children and adults.
The clinic integrates cleft reconstructive surgery, pediatric and maxillofacial surgery, dentistry, orthodontics, ear, nose and throat (ENT) care, audiology, and speech and language therapy. Rather than navigating separate appointments and specialists independently, patients and families can receive individualized treatment plans and ongoing support from a multidisciplinary team.
Cleft lip and cleft palate are congenital conditions in which the upper lip, roof of the mouth or both do not fully form during early fetal development. They may occur separately or together and can affect feeding, hearing, speech and dental development. Treatment needs vary by individual and may change over time, making coordinated, long-term care especially important.
Care begins with a comprehensive assessment of the patient’s diagnosis, medical history and previous treatment, followed by referrals to the appropriate specialists. For newborns, the team focuses on feeding and growth, offering guidance on specialist bottles and feeding techniques, monitoring intake and weight, and explaining the treatment journey to families. Early hearing assessments help identify potential concerns associated with middle-ear fluid. Expectant parents who receive a prenatal diagnosis can also seek guidance before their baby is born.
Dr. Ali Anees, Chief Operating Officer, UAE & Bahrain, Global Patient Care at M42, said: “This clinic reflects M42’s commitment to making specialized healthcare more connected, accessible and patient-centered. By integrating multidisciplinary expertise around each patient’s needs, Healthpoint is helping simplify complex care journeys and providing the continuity that patients and families deserve.”
Omar Al Naqbi, Chief Executive Officer of Healthpoint, said: “For families affected by cleft lip or palate, care extends far beyond a single procedure. Our clinic will provide clear guidance, access to the right specialists and a team that understands their journey. It brings those services together, from early feeding support and surgical planning to speech, hearing and dental care. Our goal is to help every patient and family feel informed, supported and confident at each stage.”
Where surgery is recommended, reconstructive surgeons collaborate with pediatric, maxillofacial and ENT specialists as appropriate to determine the procedure and timing based on each patient’s clinical needs, overall health and stage of development. Coordinated preparation and follow-up help ensure patients and families receive consistent guidance throughout treatment.
Follow-up care may include speech and language therapy, audiology, dentistry, orthodontics and ENT services to address evolving speech, hearing, dental, jaw and airway needs. Services are recommended according to each patient’s circumstances, including the needs of people of determination, with one coordinated team supporting continuity of care.
The clinic welcomes patients of all ages and nationalities from across the UAE. Insured patients can access services in line with their policy coverage. Patients without insurance may be considered for assistance with approved treatment expenses following case-by-case assessment.
Located at Healthpoint in Zayed Sports City, Abu Dhabi, the clinic offers services in Arabic and English.
Patients and caregivers can request an assessment by calling Healthpoint on 800 77. Healthcare professionals referring patients, including newborns with diagnosed or suspected cleft conditions, can contact the dedicated referral line on 054 340 4592.
The launch builds on Healthpoint’s expertise in reconstructive and multidisciplinary care, establishing a dedicated, year-round pathway designed to support patients from their earliest assessments through long-term follow-up.
– ENDS –
Noted to editors
ABOUT HEALTHPOINT
Healthpoint, part of the M42 group, is a multi-specialty hospital based in Abu Dhabi. The hospital includes a wide range of primary and specialty care services.
Focusing on a carefully defined set of medically integrated services and practices, Healthpoint’s patient-centered approach is organized around medical conditions over the full cycle of care and delivered in integrated practice units (IPUs).
Committed to elevating patient care to the highest standards, Healthpoint has been recognized by numerous renowned international awarding and accrediting bodies. These include the Commission on Accreditation of Rehabilitation Facilities (CARF International), the Joint Commission International (JCI), the Australian Council on Healthcare Standards International (ACHSI), and the American Surgical Review Corporation (SRC).
For more information, please visit www.healthpoint.ae
ABOUT M42
M42 is a global health leader powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver predictive, preventive and personalized care, to impactfully disrupt traditional healthcare models and positively impact lives globally.
Established in 2023, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 27 countries and over 20,000 employees. M42 includes renowned healthcare providers including Danat Al Emarat, Diaverum, Imperial College London Diabetes & Endocrine Centre (ICLDEC), Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi, Abu Dhabi’s health information exchange.
For more information, please visit https://m42.ae/
